Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria

NCT06917040 is registered in ClinicalTrials.gov with The Mentor Initiative as lead sponsor.

NCT NCT06917040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06917040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
Lead sponsor
The Mentor Initiative
Phase
Phase 3
Overall status
Completed
Start date
February 1, 2021
Completion date
April 1, 2022
Enrollment
18,404 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leishmaniasis, cutaneous, vector borne diseases